Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study.
core-needle biopsy
lymphoma diagnosis
ultrasonography
Journal
Hematological oncology
ISSN: 1099-1069
Titre abrégé: Hematol Oncol
Pays: England
ID NLM: 8307268
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
revised:
26
06
2023
received:
04
05
2023
accepted:
27
06
2023
pubmed:
7
7
2023
medline:
7
7
2023
entrez:
7
7
2023
Statut:
ppublish
Résumé
The reliability and safety of front-line ultrasonography guided core needle biopsy (UG-CNB) performed with specific uniform approach have never been evaluated in a large series of patients with lymphadenopathies suspected of lymphoma. The aim of this study was to assess the overall accuracy of UG-CNB in the lymph node histological diagnosis, using a standard reference based on pathologist consensus, molecular biology, and/or surgery. We retrospectively checked the findings concerning the application of lymph node UG-CNB from four Italian clinical units that routinely utilized 16-gauge diameter modified Menghini needle under power-Doppler ultrasonographic guidance. A data schedule was sent to all centers to investigate the information regarding techniques, results, and complications of lymph node UG-CNB in untreated patients over a 12-year period. Overall, 1000 (superficial target, n = 750; deep-seated target, n = 250) biopsies have been evaluated in 1000 patients; other 48 biopsies (4.5%), screened in the same period, were excluded because inadequate for a confident histological diagnosis. Most patients were suffering from lymphomas (aggressive B-cell non-Hodgkin lymphoma [aBc-NHL], 309 cases; indolent B-cell [iBc]-NHL, 279 cases; Hodgkin lymphoma [HL], 212 cases; and nodal peripheral T-cell [NPTC]-NHL, 30 cases) and 100 cases from metastatic carcinoma; 70 patients had non-malignant disorders. The majority of CNB results met at least one criterion of the composite reference standard. The overall accuracy of the micro-histological sampling was 97% (95% confidence interval: 95%-98%) for the series. The sensitivity of UG-CNB for the detection of aBc-NHL was 100%, for iBc-NHL 95%, for HL 93%, and for NPTC-NHL 90%, with an overall false negative rate of 3.3%. The complication rate was low (6% for all complications); no patient suffered from biopsy-related complications of grade >2 according to the Common Terminology Criteria for Adverse Events. Lymph node UG-CNB as mini-invasive diagnostic procedure is effective with minimal risk for the patient.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
817-827Informations de copyright
© 2023 The Authors. Hematological Oncology published by John Wiley & Sons Ltd.
Références
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390. https://doi.org/10.1182/blood-2016-01-643569. Epub 2016 Mar 15. PMID: 26980727; PMCID: PMC4874220.
Picardi M, Gennarelli N, Ciancia R, et al. Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. J Clin Oncol. 2004;22(18):3733-3740. https://doi.org/10.1200/jco.2004.02.171
Picardi M, Gennarelli N, Ciancia R, Spigel DR. Improving diagnostic accuracy in patients with suspected lymphoma. J Clin Outcomes Manag. 2004;11:691.
Picardi M, Ciancia R, De Renzo A, et al. Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin’s lymphoma: a prospective study. Haematologica. 2006;91:960-963.
Pugliese N, Di Perna M, Cozzolino I, et al. Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. Ann Hematol. 2017;96(4):627-637. https://doi.org/10.1007/s00277-017-2926-9
Picardi M, Giordano C, Della Pepa R, et al. Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view. Br J Haematol. 2020;190(1):837-850. Br J Haematol. 2021 Apr;193(1): e5-e8. https://doi.org/10.1111/bjh.17371. Epub 2021 Mar 4. PMID: 33660274.
Al-Abbadi M, Barroca H, Bode-Lesniewska B, et al. Letter to the Editor: fine-needle aspiration cytology and core-needle biopsy in the diagnosis of lymphadenopathies: words of endorsement. Eur J Haematol. 2021;107(2):295-296. https://doi.org/10.1111/ejh.13646. Epub 2021 May 27. PMID: 33961309.
Hu Q, Naushad H, Xie Q, Al-Howaidi I, Wang M, Fu K. Needle-core biopsy in the pathologic diagnosis of malignant lymphoma showing high reproducibility among pathologists. Am J Clin Pathol. 2013;140(2):238-247. https://doi.org/10.1309/ajcp9zagkvj8pdax
Pizzi M, Agostinelli C, Santoro L, et al. Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: a word of caution. Eur J Haematol. 2021;106(5):737-739. https://doi.org/10.1111/ejh.13578
Good DJ, Gascoyne RD. Atypical lymphoid hyperplasia mimicking lymphoma. Hematol Oncol Clin N Am. 2009;23(4):729-745. https://doi.org/10.1016/j.hoc.2009.04.005
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068. https://doi.org/10.1200/JCO.2013.54.8800. PMID: 25113753; PMCID: PMC4979083.
Johl A, Lengfelder E, Hiddemann W, Klapper W. Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel. Ann Hematol. 2016;95(8):1281-1286. https://doi.org/10.1007/s00277-016-2704-0
Pruneri G, Gigli F, Rafaniello Raviele P, et al. Core needle biopsy as a front line diagnostic approach for lymphoma patients. Hematol Oncol. 2015;33(4):247-249. https://doi.org/10.1002/hon.2150. Epub 2014 Jul 2. PMID: 24986739. Oncol 2015; 33: 247-249.
Picardi M, Pugliese N, Cirillo M, et al. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission-a randomized trial of routine surveillance imaging procedures. Radiology. 2014;272(1):262-274. https://doi.org/10.1148/radiol.14132154
Zelenetz AD, Gordon LI, Chang JE, et al. NCCN Guidelines® insights: B-cell lymphomas, version 5.2021. J Natl Compr Cancer Netw. 2021;19(11):1218-1230. https://doi.org/10.6004/jnccn.2021.0054
Hoppe RT, Advani RH, Ai WZ, et al. Hodgkin lymphoma, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2020;18(6):755-781. https://doi.org/10.6004/jnccn.2020.0026
Horwitz SM, Ansell S, Ai WZ, et al. T-cell lymphomas, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(3):285-308. https://doi.org/10.6004/jnccn.2022.0015
Syrykh C, Chaouat C, Poullot E, et al. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey. Blood. 2022;140(24):2573-2583. blood.2022015520. https://doi.org/10.1182/blood.2022015520. Epub ahead of print. PMID: 35797472.
Eichenauer DA, Engert A, Andre M, et al. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol. 2014;25(Suppl 3):iii70-iii75. https://doi.org/10.1093/annonc/mdu181
Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, Ladetto M. Newly diagnosed and relapsed follicular lymphoma: ESMO Ann Hematol (2016) 95:1281-1286 1285 Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii76-iii82. https://doi.org/10.1093/annonc/mdu200
Tilly H, da Gomes SM, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116-v125. https://doi.org/10.1093/annonc/mdv304
Shimizu I, Okazaki Y, Takeda W, et al. Use of percutaneous image-guided coaxial core-needle biopsy for diagnosis of intraabdominal lymphoma. Cancer Med. 2014;3(5):1336-1341. https://doi.org/10.1002/cam4.224
Assaf N, Nassif S, Tamim H, Bazarbachi A, Zaatari G, Chakhachiro Z. Diagnosing lymphoproliferative disorders using core needle biopsy versus surgical excisional biopsy: three-year experience of a reference center in Lebanon. Clin Lymphoma Myeloma Leuk. 2020;20(8):e455-e460. https://doi.org/10.1016/j.clml.2019.11.013. Epub 2019 Nov 21. PMID: 32461041.
Kraft M, Laeng H, Schmuziger N, Arnoux A, Gurtler N. Comparison of ultrasound-guided core-needle biopsy and fine needle aspiration in the assessment of head and neck lesions. Head Neck. 2008;30(11):1457-1463. https://doi.org/10.1002/hed.20891
Velasco Garrido M, Gerhardus A, Røttingen JA, Busse R. Developing Health Technology Assessment to address health care system needs. Health Pol. 2010;94(3):196-202. https://doi.org/10.1016/j.healthpol.2009.10.002. Epub 2009 Nov 3. PMID: 19889471.